Original Paper
Oncogene (2003) 22, 8145–8155. doi:10.1038/sj.onc.1206997
WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2
Maria Teresa Discenza1, Shujie He2, Tae Ho Lee1, Lee Lee Chu1, Brad Bolon3, Paul Goodyer4, Michael Eccles2,4,6 and Jerry Pelletier1,5,6
- 1Department of Biochemistry, McGill University, Montreal, Quebec, Canada
- 2Department of Pathology, University of Otago, Dunedin, New Zealand
- 3Department of Pathology, Amgen, Inc., Thousand Oaks, CA, USA
- 4Department of Pediatrics, Montreal Children's Hospital, McGill University, Montreal, Quebec, Canada
- 5McGill Cancer Center, McGill University, Montreal, Quebec, Canada
Correspondence: M Eccles, Department of Pathology, Hercus Building Hanover Street, University of Otago, PO Box 913, Dunedin 9015, New Zealand. E-mail: meccles@otago.ac.nz
6Both these authors contributed equally to this work
Received 15 January 2003; Revised 19 May 2003; Accepted 15 July 2003.
Abstract
Metanephric kidney development requires an inductive interaction between the ureteric bud and progenitor mesenchyme, where the early expression of two genes, Wilms' tumour 1 (WT1) and paired box 2 (Pax2), establishes critical but unknown developmental pathways. Indeed, transgenic mice with deregulated overexpression of Pax2 exhibit structural kidney defects and impaired renal function, as do mice harboring targeted disruptions and/or spontaneous mutations of either the Pax2 or WT1 genes. WT1 and Pax2 are thought to regulate each other's expression during renal development. To better define the relationship between WT1 and Pax2, we generated mouse embryos containing heterozygous mutations in both genes. WT1+/-/Pax21Neu/+ kidneys were 50% smaller than wild-type kidneys. They were characterized by severe attenuation of the renal medulla, and reduced development of calyces and the renal pelvis. Renal cortex development in compound heterozygotes culminated in fewer nephrons than in WT1+/-, Pax21Neu/+ or wild-type mice. Only minor variations in the mesenchymal expression pattern of Pax2 protein, and the mRNA expression levels of Pax2 and WT1, were noted in mutant kidneys. We show that WT1 and Pax2 proteins interact in vitro and in vivo, demonstrating that WT1 and Pax2 can form a molecular complex. Our data suggest that WT1 is a modifier of the Pax2 mutant phenotype.
Keywords:
WT1, Pax2, kidney development, protein–protein interactions
